Position in OCGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,125,265
+$1,992,058 QoQ
Shares Held
1,174,180
+1090.0% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Derivatives in OCGN
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$1,047,410
PutShares
230,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,114,641,102 across 347 Biotechnology names. OCGN ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,836 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,181 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,989 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,940 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in OCGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,125,265 | 1,174,180 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $133,207 | 98,672 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $251,626 | 154,372 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $78,763 | 81,199 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $99,922 | 141,533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $304,760 | 378,587 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $954,521 | 962,221 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $993,658 | 641,071 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $449,002 | 273,783 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $89,227 | 155,181 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $81,753 | 204,385 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $201,796 | 371,635 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $417,988 | 490,023 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,742,903 | 2,879,157 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,463,255 | 1,945,650 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,766,366 | 1,218,664 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,206,467 | 2,789,839 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,292,718 | 1,163,235 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $1,047,410 | 230,200 | Put | Defined | 2022-02-08 | |
| 2021-09-30 | $726,500 | 101,184 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $162,986 | 22,700 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $20,770,398 | 2,586,600 | Put | Defined | 2021-09-13 | |
| 2021-06-30 | $3,449,374 | 429,561 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $279,645 | 41,185 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $8,871,814 | 1,306,600 | Put | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||